Ilika plc signs MOU with Cirtec Medical

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced it has broadened its relationship with Cirtec Medical, an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a memorandum of understanding which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, Massachusetts, U.S.

Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialisation activities. This partnership will reinforce Cirtec’s ongoing activities in system level miniaturisation for the medical device industry. Benefits of this partnership, to Ilika, include:

·    Further validation of Stereax’s capabilities

·    Manufacturing partnership delivering economy of scale and ability to rapidly ramp production

·    Expanded business development team bringing additional commercial momentum

In due course Ilika and Cirtec envisage signing a contract once the terms of the partnership have been finalised and a further announcement will be made at this time.

Graeme Purdy, Ilika Plc’s Chief Executive Officer, said: “Our partnership with Cirtec reinforces a pathway towards commercialisation of our Stereax battery technology. Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialisation in the medical device industry.”

Brian Highley, Cirtec Medical Chief Executive Officer, commented: “With over 20 years of experience in the design, development and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets.”

Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:
Ilika plc reports impressive 2024 half-year results, advancing solid-state battery tech with Stereax and Goliath for MedTech and EV applications.
Ilika plc's CEO, Graeme Purdy, discusses the successful commissioning of Stereax batteries at Cirtec, product qualification, and future developments.
Ilika plc advances solid-state battery tech with Stereax® production starting in the US, marking a pivotal step towards commercial sales this year.
Ilika Plc CEO Graeme Purdy discusses Stereax battery production at Certec, marking a key milestone in solid-state tech and medtech applications.
Ilika plc begins process qualification for Stereax batteries at Cirtec Medical's facility, marking a key step in advanced solid state battery production.
Ilika plc appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker, enhancing its solid-state battery technology ventures.

Search

Search